Legend Biotech Corp ADR (NASDAQ:LEGN) currently has a daily average trading volume of 1.49M but it saw 2779840 shares traded in last market. With a market cap of 5.21B USD, the company’s current market price of $28.33 came falling about -5.79 while comparing to the previous closing price of $30.07. In past 52 weeks, the stock remained buoying in the range of price level as high as $60.87 and as low as $27.34.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Redburn Atlantic which initiated the stock as “Buy” in its note to investors issued on October 08, 2024, recommending a price target of $86 for it. H.C. Wainwright issued its recommendations for the stock as it reiterated the price target for the stock in the range of between $86 and $73.
Over the week, LEGN’s stock price is moving 1.91% up while it is -17.84% when we observe its performance for the past one month. Year-to-date it is -12.94% down and over the past year, the stock is showing a downside performance of -37.27%.
Currently, Legend Biotech Corp ADR’s total number of outstanding shares is 184.03M with 1.33% of that held by the insiders while 48.01% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -15.86% and return on equity (ROE) at -20.00%. It has a 52.06 of forward P/E ratio. Stock’s beta reads 0.14. Stock has a price to book (P/B) ratio of 5.12 while price to sale or P/S ratio amounts to 7.16. Its return on asset (ROA) is -12.87% on average.
